304 related articles for article (PubMed ID: 10662606)
1. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
Clarke DO; Elswick BA; Welsch F; Conolly RB
Toxicol Appl Pharmacol; 1993 Aug; 121(2):239-52. PubMed ID: 8346541
[TBL] [Abstract][Full Text] [Related]
3. A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human.
Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
Toxicol Appl Pharmacol; 2000 May; 165(1):53-62. PubMed ID: 10814553
[TBL] [Abstract][Full Text] [Related]
4. Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse.
Terry KK; Elswick BA; Welsch F; Conolly RB
Toxicol Appl Pharmacol; 1995 May; 132(1):103-14. PubMed ID: 7747273
[TBL] [Abstract][Full Text] [Related]
5. Developmental phase alters dosimetry-teratogenicity relationship for 2-methoxyethanol in CD-1 mice.
Terry KK; Elswick BA; Stedman DB; Welsch F
Teratology; 1994 Mar; 49(3):218-27. PubMed ID: 8059429
[TBL] [Abstract][Full Text] [Related]
6. Teratologic potential of 2-methoxyethanol and transplacental distribution of its metabolite, 2-methoxyacetic acid, in non-human primates.
Scott WJ; Fradkin R; Wittfoht W; Nau H
Teratology; 1989 Apr; 39(4):363-73. PubMed ID: 2749579
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based pharmacokinetics of methoxyacetic acid: dose-effect considerations in C57BL/6 mice.
O'Flaherty EJ; Nau H; McCandless D; Beliles RP; Schreiner CM; Scott WJ
Teratology; 1995 Aug; 52(2):78-89. PubMed ID: 8588185
[TBL] [Abstract][Full Text] [Related]
8. A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human.
Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
Toxicol Appl Pharmacol; 2000 May; 165(1):63-73. PubMed ID: 10814554
[TBL] [Abstract][Full Text] [Related]
9. Dose effects on the excretion of urinary metabolites of 2-[1,2,methoxy-13C]methoxyethanol in rats and mice.
Sumner SJ; Stedman DB; Cheng SY; Welsch F; Fennell TR
Toxicol Appl Pharmacol; 1995 Sep; 134(1):139-47. PubMed ID: 7676448
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxyethanol metabolism, embryonic distribution, and macromolecular adduct formation in the rat: the effect of radiofrequency radiation-induced hyperthermia.
Cheever KL; Swearengin TF; Edwards RM; Nelson BK; Werren DW; Conover DL; DeBord DG
Toxicol Lett; 2001 May; 122(1):53-67. PubMed ID: 11397557
[TBL] [Abstract][Full Text] [Related]
11. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice.
Ward KW; Blumenthal GM; Welsch F; Pollack GM
Toxicol Appl Pharmacol; 1997 Aug; 145(2):311-22. PubMed ID: 9266804
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of ethylene glycol ether reproductive and developmental toxicity and evidence for adverse effects in humans.
Welsch F
Toxicol Lett; 2005 Mar; 156(1):13-28. PubMed ID: 15705484
[TBL] [Abstract][Full Text] [Related]
13. A physiologically based pharmacokinetic computer model for human pregnancy.
Luecke RH; Wosilait WD; Pearce BA; Young JF
Teratology; 1994 Feb; 49(2):90-103. PubMed ID: 8016750
[TBL] [Abstract][Full Text] [Related]
14. 2-Methoxyacetic acid dosimetry-teratogenicity relationships in CD-1 mice exposed to 2-methoxyethanol.
Clarke DO; Duignan JM; Welsch F
Toxicol Appl Pharmacol; 1992 May; 114(1):77-87. PubMed ID: 1585375
[TBL] [Abstract][Full Text] [Related]
15. The relationship of embryotoxicity to disposition of 2-methoxyethanol in mice.
Sleet RB; Greene JA; Welsch F
Toxicol Appl Pharmacol; 1988 Apr; 93(2):195-207. PubMed ID: 3358259
[TBL] [Abstract][Full Text] [Related]
16. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
17. Teratogenicity of dimethoxyethyl phthalate and its metabolites methoxyethanol and methoxyacetic acid in the rat.
Ritter EJ; Scott WJ; Randall JL; Ritter JM
Teratology; 1985 Aug; 32(1):25-31. PubMed ID: 4035589
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments.
Welsch F; Blumenthal GM; Conolly RB
Toxicol Lett; 1995 Dec; 82-83():539-47. PubMed ID: 8597107
[TBL] [Abstract][Full Text] [Related]
19. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
Corley RA; Grant DM; Farris E; Weitz KK; Soelberg JJ; Thrall KD; Poet TS
Toxicol Lett; 2005 Mar; 156(1):127-61. PubMed ID: 15705493
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyethanol metabolism in pregnant CD-1 mice and embryos.
Mebus CA; Clarke DO; Stedman DB; Welsch F
Toxicol Appl Pharmacol; 1992 Jan; 112(1):87-94. PubMed ID: 1733052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
